STI
39
10
IPG
50
-2
LEG
53
-4
KMX
54
-4
AON
65
-4
LLY
70
2
ICE
50
-5
LEN
44
-4
BAX
47
-6
SIG
41
-3
XRAY
40
-6
KSS
36
-3
CAT
72
10
QCOM
59
-3
PGR
33
-4
EMN
63
-2
USB
66
-3
AA
70
-2
NSC
65
12
NRG
60
11
STI
39
10
IPG
50
-2
LEG
53
-4
KMX
54
-4
AON
65
-4
LLY
70
2
ICE
50
-5
LEN
44
-4
BAX
47
-6
SIG
41
-3
XRAY
40
-6
KSS
36
-3
CAT
72
10
QCOM
59
-3
PGR
33
-4
EMN
63
-2
USB
66
-3
AA
70
-2
NSC
65
12
NRG
60
11
Financhill
Back

Minerva Neurosciences 10K Form

Sell
22

NERV
Minerva Neurosciences

Last Price:
$1.65
Seasonality Move:
11.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NERV News And Ratings

See the #1 stock for the next 7 days that we like better than NERV

NERV Financial Statistics

Sales & Book Value

Annual Sales: $41.2M
Cash Flow: $-4.1M
Price / Cash Flow: 0
Annual Sales: $-4.17
Price / Book: 0

Profitability

EPS (TTM): 0.82000
Net Income (TTM): $6.3M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Minerva Neurosciences Earnings Forecast

Key Minerva Neurosciences Financial Ratios

  • The Selling, General & Administrative Expenses for NERV have been equal to 41.99% of Gross Profit Margin.
  • The Interest Expense is 317.07% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

Minerva Neurosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NERV
CUSIP: 603380
Website: minervaneurosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 8.84
Forward P/E Ratio: 0

NERV Technical Analysis vs Fundamental Analysis

Sell
22
Minerva Neurosciences (NERV) is a Sell

Is Minerva Neurosciences a Buy or a Sell?